Evidence map›Paper›PMID 15997358›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2005

[Automated external defibrillators: perspectives and outlook].

H-R Arntz, H-J Trappe

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

H-R ArntzCharité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Med. Klinik II, Kardiologie und Pulmologie, Hindenburgdamm 30, 12200 Berlin. hans-richard.arntz@charite.de
H-J Trappe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Germany about 80.000 patients die of sudden cardiac death each year with enormous human, social and economic consequences. Most cases of sudden cardiac death are caused by ischemia-triggered ventricular fibrillation. A precondition for survival of the victims is an optimally and fast reacting "chain of survival". One of the central links of this chain is timely defibrillation, which is the only effective therapy for treatment of ventricular fibrillation. Automated external defibrillators proved to be a major step forward in improvement of resuscitation results. It has been convincingly demonstrated, that these devices not only are safe and efficacious in the hands of rescue personnel of different qualification degrees but also in the hands of minimally trained "first responders" and even in the hands of untrained lay people. This story of success was paralleled by the development of a new generation of biphasic defibrillators, which have a superior efficacy, are lightweight and are even cheaper than conventional devices. It must however kept in mind, that progress offered by these new opportunities will only translate in better resuscitation results, when programmes are thoroughly planned, will stay under continuous quality control with regard to performance of devices and rescuers and if new knowledge in resuscitation is adequately incorporated in action protocols.

Indexed as

DefibrillatorsCardiopulmonary ResuscitationCritical CareElectric CountershockEmergency Medical ServicesEquipment DesignGermanyVentricular Fibrillation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.